Precision Medicine in Pancreatic Disease-Knowledge Gaps and Research Opportunities: Summary of a National Institute of Diabetes and Digestive and Kidney Diseases Workshop

Mark E. Lowe, Dana K. Andersen, Richard M. Caprioli, Jyoti Choudhary, Zobeida Cruz-Monserrate, Anil K. Dasyam, Christopher E. Forsmark, Fred S. Gorelick, Joe W. Gray, Mark Haupt, Kimberly A. Kelly, Kenneth P. Olive, Sylvia K. Plevritis, Noa Rappaport, Holger R. Roth, Hanno Steen, S. Joshua Swamidass, Temel Tirkes, Aliye Uc, Kirill VeselkovDavid C. Whitcomb, Aida Habtezion

Research output: Contribution to journalArticle

Abstract

A workshop on research gaps and opportunities for Precision Medicine in Pancreatic Disease was sponsored by the National Institute of Diabetes and Digestive Kidney Diseases on July 24, 2019, in Pittsburgh. The workshop included an overview lecture on precision medicine in cancer and 4 sessions: (1) general considerations for the application of bioinformatics and artificial intelligence; (2) omics, the combination of risk factors and biomarkers; (3) precision imaging; and (4) gaps, barriers, and needs to move from precision to personalized medicine for pancreatic disease. Current precision medicine approaches and tools were reviewed, and participants identified knowledge gaps and research needs that hinder bringing precision medicine to pancreatic diseases. Most critical were (a) multicenter efforts to collect large-scale patient data sets from multiple data streams in the context of environmental and social factors; (b) new information systems that can collect, annotate, and quantify data to inform disease mechanisms; (c) novel prospective clinical trial designs to test and improve therapies; and (d) a framework for measuring and assessing the value of proposed approaches to the health care system. With these advances, precision medicine can identify patients early in the course of their pancreatic disease and prevent progression to chronic or fatal illness.

Original languageEnglish (US)
Pages (from-to)1250-1258
Number of pages9
JournalPancreas
Volume48
Issue number10
DOIs
StatePublished - Nov 1 2019
Externally publishedYes

Fingerprint

National Institute of Diabetes and Digestive and Kidney Diseases (U.S.)
Pancreatic Diseases
Precision Medicine
Education
Research
Artificial Intelligence
Computational Biology
Information Systems
Disease Progression
Biomarkers
Clinical Trials
Delivery of Health Care

ASJC Scopus subject areas

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism
  • Hepatology
  • Endocrinology

Cite this

Precision Medicine in Pancreatic Disease-Knowledge Gaps and Research Opportunities : Summary of a National Institute of Diabetes and Digestive and Kidney Diseases Workshop. / Lowe, Mark E.; Andersen, Dana K.; Caprioli, Richard M.; Choudhary, Jyoti; Cruz-Monserrate, Zobeida; Dasyam, Anil K.; Forsmark, Christopher E.; Gorelick, Fred S.; Gray, Joe W.; Haupt, Mark; Kelly, Kimberly A.; Olive, Kenneth P.; Plevritis, Sylvia K.; Rappaport, Noa; Roth, Holger R.; Steen, Hanno; Swamidass, S. Joshua; Tirkes, Temel; Uc, Aliye; Veselkov, Kirill; Whitcomb, David C.; Habtezion, Aida.

In: Pancreas, Vol. 48, No. 10, 01.11.2019, p. 1250-1258.

Research output: Contribution to journalArticle

Lowe, ME, Andersen, DK, Caprioli, RM, Choudhary, J, Cruz-Monserrate, Z, Dasyam, AK, Forsmark, CE, Gorelick, FS, Gray, JW, Haupt, M, Kelly, KA, Olive, KP, Plevritis, SK, Rappaport, N, Roth, HR, Steen, H, Swamidass, SJ, Tirkes, T, Uc, A, Veselkov, K, Whitcomb, DC & Habtezion, A 2019, 'Precision Medicine in Pancreatic Disease-Knowledge Gaps and Research Opportunities: Summary of a National Institute of Diabetes and Digestive and Kidney Diseases Workshop', Pancreas, vol. 48, no. 10, pp. 1250-1258. https://doi.org/10.1097/MPA.0000000000001412
Lowe, Mark E. ; Andersen, Dana K. ; Caprioli, Richard M. ; Choudhary, Jyoti ; Cruz-Monserrate, Zobeida ; Dasyam, Anil K. ; Forsmark, Christopher E. ; Gorelick, Fred S. ; Gray, Joe W. ; Haupt, Mark ; Kelly, Kimberly A. ; Olive, Kenneth P. ; Plevritis, Sylvia K. ; Rappaport, Noa ; Roth, Holger R. ; Steen, Hanno ; Swamidass, S. Joshua ; Tirkes, Temel ; Uc, Aliye ; Veselkov, Kirill ; Whitcomb, David C. ; Habtezion, Aida. / Precision Medicine in Pancreatic Disease-Knowledge Gaps and Research Opportunities : Summary of a National Institute of Diabetes and Digestive and Kidney Diseases Workshop. In: Pancreas. 2019 ; Vol. 48, No. 10. pp. 1250-1258.
@article{72bd0d44d5374484a789732964455d25,
title = "Precision Medicine in Pancreatic Disease-Knowledge Gaps and Research Opportunities: Summary of a National Institute of Diabetes and Digestive and Kidney Diseases Workshop",
abstract = "A workshop on research gaps and opportunities for Precision Medicine in Pancreatic Disease was sponsored by the National Institute of Diabetes and Digestive Kidney Diseases on July 24, 2019, in Pittsburgh. The workshop included an overview lecture on precision medicine in cancer and 4 sessions: (1) general considerations for the application of bioinformatics and artificial intelligence; (2) omics, the combination of risk factors and biomarkers; (3) precision imaging; and (4) gaps, barriers, and needs to move from precision to personalized medicine for pancreatic disease. Current precision medicine approaches and tools were reviewed, and participants identified knowledge gaps and research needs that hinder bringing precision medicine to pancreatic diseases. Most critical were (a) multicenter efforts to collect large-scale patient data sets from multiple data streams in the context of environmental and social factors; (b) new information systems that can collect, annotate, and quantify data to inform disease mechanisms; (c) novel prospective clinical trial designs to test and improve therapies; and (d) a framework for measuring and assessing the value of proposed approaches to the health care system. With these advances, precision medicine can identify patients early in the course of their pancreatic disease and prevent progression to chronic or fatal illness.",
author = "Lowe, {Mark E.} and Andersen, {Dana K.} and Caprioli, {Richard M.} and Jyoti Choudhary and Zobeida Cruz-Monserrate and Dasyam, {Anil K.} and Forsmark, {Christopher E.} and Gorelick, {Fred S.} and Gray, {Joe W.} and Mark Haupt and Kelly, {Kimberly A.} and Olive, {Kenneth P.} and Plevritis, {Sylvia K.} and Noa Rappaport and Roth, {Holger R.} and Hanno Steen and Swamidass, {S. Joshua} and Temel Tirkes and Aliye Uc and Kirill Veselkov and Whitcomb, {David C.} and Aida Habtezion",
year = "2019",
month = "11",
day = "1",
doi = "10.1097/MPA.0000000000001412",
language = "English (US)",
volume = "48",
pages = "1250--1258",
journal = "Pancreas",
issn = "0885-3177",
publisher = "Lippincott Williams and Wilkins",
number = "10",

}

TY - JOUR

T1 - Precision Medicine in Pancreatic Disease-Knowledge Gaps and Research Opportunities

T2 - Summary of a National Institute of Diabetes and Digestive and Kidney Diseases Workshop

AU - Lowe, Mark E.

AU - Andersen, Dana K.

AU - Caprioli, Richard M.

AU - Choudhary, Jyoti

AU - Cruz-Monserrate, Zobeida

AU - Dasyam, Anil K.

AU - Forsmark, Christopher E.

AU - Gorelick, Fred S.

AU - Gray, Joe W.

AU - Haupt, Mark

AU - Kelly, Kimberly A.

AU - Olive, Kenneth P.

AU - Plevritis, Sylvia K.

AU - Rappaport, Noa

AU - Roth, Holger R.

AU - Steen, Hanno

AU - Swamidass, S. Joshua

AU - Tirkes, Temel

AU - Uc, Aliye

AU - Veselkov, Kirill

AU - Whitcomb, David C.

AU - Habtezion, Aida

PY - 2019/11/1

Y1 - 2019/11/1

N2 - A workshop on research gaps and opportunities for Precision Medicine in Pancreatic Disease was sponsored by the National Institute of Diabetes and Digestive Kidney Diseases on July 24, 2019, in Pittsburgh. The workshop included an overview lecture on precision medicine in cancer and 4 sessions: (1) general considerations for the application of bioinformatics and artificial intelligence; (2) omics, the combination of risk factors and biomarkers; (3) precision imaging; and (4) gaps, barriers, and needs to move from precision to personalized medicine for pancreatic disease. Current precision medicine approaches and tools were reviewed, and participants identified knowledge gaps and research needs that hinder bringing precision medicine to pancreatic diseases. Most critical were (a) multicenter efforts to collect large-scale patient data sets from multiple data streams in the context of environmental and social factors; (b) new information systems that can collect, annotate, and quantify data to inform disease mechanisms; (c) novel prospective clinical trial designs to test and improve therapies; and (d) a framework for measuring and assessing the value of proposed approaches to the health care system. With these advances, precision medicine can identify patients early in the course of their pancreatic disease and prevent progression to chronic or fatal illness.

AB - A workshop on research gaps and opportunities for Precision Medicine in Pancreatic Disease was sponsored by the National Institute of Diabetes and Digestive Kidney Diseases on July 24, 2019, in Pittsburgh. The workshop included an overview lecture on precision medicine in cancer and 4 sessions: (1) general considerations for the application of bioinformatics and artificial intelligence; (2) omics, the combination of risk factors and biomarkers; (3) precision imaging; and (4) gaps, barriers, and needs to move from precision to personalized medicine for pancreatic disease. Current precision medicine approaches and tools were reviewed, and participants identified knowledge gaps and research needs that hinder bringing precision medicine to pancreatic diseases. Most critical were (a) multicenter efforts to collect large-scale patient data sets from multiple data streams in the context of environmental and social factors; (b) new information systems that can collect, annotate, and quantify data to inform disease mechanisms; (c) novel prospective clinical trial designs to test and improve therapies; and (d) a framework for measuring and assessing the value of proposed approaches to the health care system. With these advances, precision medicine can identify patients early in the course of their pancreatic disease and prevent progression to chronic or fatal illness.

UR - http://www.scopus.com/inward/record.url?scp=85074550484&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85074550484&partnerID=8YFLogxK

U2 - 10.1097/MPA.0000000000001412

DO - 10.1097/MPA.0000000000001412

M3 - Article

C2 - 31688587

AN - SCOPUS:85074550484

VL - 48

SP - 1250

EP - 1258

JO - Pancreas

JF - Pancreas

SN - 0885-3177

IS - 10

ER -